The Prescription Drug Affordability Board is finally moving on the task for which it was created back in 2019 – ensuring so called high-cost prescription drugs are affordable for Marylanders.
Semaglutide and tirzepatide are both glucagon-like peptide-1 receptor agonists or GLP-1 agonists. Although originally ...
In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...
Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...
Meaning, whether you lose weight through a change in your diet, a different medication, or bariatric surgery, there is a risk ...
Revolutionizing Healthcare Access with Culturally Focused, Language-Accessible Care TAMPA, Fla., Sept. 19, 2024 (GLOBE ...
The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here's what doctors think ...
Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...
Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...
NanoVation will receive $600m in upfront cash and potential milestone payments, as well as tiered royalties on future product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback